+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Anti Peptic Ulcer Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

Pre Book Price: $ 5216

Original Price: $ 5795

An anti-peptic ulcer drug is a class of drugs used for the treatment of most common ulcers in stomach and upper part of small intestine. These drugs act by decreasing the levels of gastric acidity or by enhancing the protection for mucosa. Major causes of peptic ulcer are Helicobacter pylori (H. pylori) infection or due to long-term use of drugs such as aspirin, ibuprofen and non-steroidal anti-inflammatory drugs (NSAIDs).

Anti-peptic ulcer drugs market is classified based on:
  • Drug class
    • Proton pump inhibitor
    • H2 receptor antagonist
    • Gastric mucosal protective drugs
    • Antacid
    • Antibiotics
    • Others
At present, North America dominates the global anti-peptic ulcer drugs market and is followed by Europe. Anti-peptic ulcer drugs market growth in these regions is attributed to high incidence of people suffering from peptic ulcers and large number of patents expected to expire and thereby allowing entry of generics. Developing nations of Latin America such as Brazil, Argentina and Chile as well as Middle East Asian countries are expected to show rapid growth in demand for anti-peptic ulcer drugs due to poor sanitization and hygienic practices causing H. pylori infections in these regions. Higher incidence of peptic acid ulcers is boosting the production and marketing of anti-peptic ulcer drugs in Asia-Pacific regions such as India, China, and Australia.

Some of the key factors driving the market for anti-peptic ulcer drugs are increase in patient pool with H. pylori infection, stressed lifestyles, advances in peptic ulcer therapies and patent exclusivity expiration leading to decline in revenues and the resultant high generic competition. 

Some of the key players contributing in anti-peptic ulcer market are AstraZeneca PLC, Daewoong Pharmaceutical Co., Ltd., Eisai Co., Ltd., HeliCure AB, Ore Pharmaceuticals, Inc., Sihuan Pharmaceutical Holdings Group Ltd. and Takeda Pharmaceutical Company Limited. 

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include 
  • North America 
  • Asia Pacific 
  • Europe
  • Rest of the World  
This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a technological growth map over time to understand the industry growth rate
  • It provides a seven-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top